Search Results 981-990 of 8632 for Endemic
Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) · Overview.
The primary purpose of this study is to compare 1 year graft-versus-host disease (GVHD)-free, graft relapse-free survival (GRFS) between the two GVHD ...
Trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant eligibility ...
Science Saturday: Mayo Clinic doctor visits of the future could be powered by 'omics' research. Susan Murphy. May 27, 2023.
Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to determine 3- and 5-year disease-free survival (DFS) among patients undergoing pulmonary segmentectomy for ...
About this study. Primary Biliary Cirrhosis (PBC) is a serious, life--threatening, bile acid related liver disease of unknown cause.
The purpose of this study is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio. Participation eligibility.
About this study. The purpose of this study is to determine if a 6 month supply (1 meal//day) of healthy food choices readily available in the patients home ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.